Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

CONCLUSIONS: Moderate-quality evidence shows no differences in effects of adenosine and calcium channel antagonists for treatment of SVT on reverting to sinus rhythm, and low-quality evidence suggests no appreciable differences in the incidence of hypotension. A study comparing patient experiences and prospectively studied adverse events would provide evidence on which treatment is preferable for management of SVT. PMID: 29025197 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29025197?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - October 12, 2017 Category: General Medicine Authors: Alabed S, Sabouni A, Providencia R, Atallah E, Qintar M, Chico TJ Tags: Cochrane Database Syst Rev Source Type: research